Ansell Healthcare Re-Launches Improved Micro-Touch® Nitrile Exam Gloves
Ansell Healthcare Products LLC announces it has re-engineered its Micro-Touch® Nitrile Exam Gloves to help reduce hand fatigue, increase dexterity and tactile sensitivity, and improve wet and dry grip performance.
The latex-free, powder-free exam gloves have been upgraded with an advanced stretch formulation to provide outstanding comfort and excellent puncture and tear resistance. These enhancements provide fit, comfort and performance not normally associated with a synthetic exam glove.
Micro-Touch® Nitrile gloves are made from 100 percent nitrile, addressing Type 1 (latex-sensitive) allergy issues – a growing concern for both patient and healthcare worker safety and protection. They are also powder-free to protect workers’ skin from cornstarch-induced dryness and irritation, while also protecting patients from other complications related to glove powder.
The gloves meet or exceed American Society for Testing and Materials and FDA-QSR standards and comply with ASTM D6319, the standard specification for nitrile exam gloves. They are also FDA-approved for use with certain chemotherapy drugs.
Available in X-Small to X-Large sizes, Micro-Touch® Nitrile’s unique blue color makes it easily identifiable as a nitrile glove.
Source: Ansell
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.
